| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |